These comparisons
of the two dose levels with placebo suggest that there is no
difference between higher- and lower-dose aspirin in the effect on all
adenomas and that higher-dose aspirin provides a greater risk reduction
than lower-dose aspirin for advanced lesions. However, a direct
comparison of higher-dose vs lower-dose aspirin showed statistically
signifi cantly greater risk reduction for all adenomas with lower-dose
aspirin